Spectrum of medication-induced complications in the abdomen: Role of cross-sectional imaging

American Journal of Roentgenology

Volumn 197, Issue 2, 2011, Pages

  Shanbhogue, Alampady Krishna Prasad ^a   Virmani, Vivek ^b   Vikram, Raghu ^a   Prasad, Srinivasa R ^a   Shanbhogue, Divya K P ^a   Nagar, Arpit ^a   Fasih, Najla ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Abdomen; Complication; Cross sectional imaging; Medication

Indexed keywords

AMOXICILLIN; ANABOLIC AGENT; ANTICOAGULANT AGENT; BARBITURIC ACID DERIVATIVE; BCG VACCINE; BLEOMYCIN; BUSULFAN; CISPLATIN; CLOMIFENE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLLITROPIN; IMIDAZOLECARBOXAMIDE; IMMUNOSUPPRESSIVE AGENT; IRINOTECAN; OMEPRAZOLE; ORAL CONTRACEPTIVE AGENT; OXALIPLATIN; TAMOXIFEN; THORIUM DIOXIDE; TIOGUANINE; UNINDEXED DRUG; VINBLASTINE; VINYL CHLORIDE;

ABDOMINAL DISEASE; ACUTE PANCREATITIS; AORTA ANEURYSM; BLEEDING; BREAST CANCER; CARCINOMA; CARCINOSARCOMA; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG FEVER; DRUG INDUCED DISEASE; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FATTY LIVER; HEMORRHAGIC CYSTITIS; HEPATITIS; HUMAN; ISCHEMIC COLITIS; KIDNEY DYSFUNCTION; LIVER ADENOMA; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HYPERPLASIA; LIVER HYPERTROPHY; LIVER NECROSIS; LIVER PARENCHYMA; LIVER TUMOR; LIVER VEIN OBSTRUCTION; LIVER VENOOCCLUSIVE DISEASE; LYMPHOPROLIFERATIVE DISEASE; MENETRIER DISEASE; MIXED TUMOR; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEPHROGENIC DIABETES INSIPIDUS; NEUTROPENIC ENTEROCOLITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY HYPERSTIMULATION; PELIOSIS HEPATIS; PNEUMATOSIS INTESTINALIS; PNEUMONIA; POLYP; PRIORITY JOURNAL; REVIEW; SARCOMA; SCLEROSING CHOLANGITIS; SEPSIS; SINUSOIDAL OBSTRUCTIVE SYNDROME; TUMOR LYSIS SYNDROME; ZOLLINGER ELLISON SYNDROME;

CONTRAST MEDIA; DIGESTIVE SYSTEM DISEASES; DRUG THERAPY; FEMALE; FEMALE UROGENITAL DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MALE UROGENITAL DISEASES; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR DISEASES;

EID: 79960718882     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.5415     Document Type: Review

References (55)

1. Cronin CG, O'Connor M, Lohan DG, et al. Imaging of the gastrointestinal complications of systemic chemotherapy. Clin Radiol 2009; 64:724-733
2. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 1995; 333:1118-1127
3. Peppercorn PD, Reznek RH, Wilson P, Slevin ML, Gupta RK. Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer 1998; 77:2008-2011 (Pubitemid 28254648)
4. Ogawa Y, Murata Y, Nishioka A, Inomata T, Yoshida S. Tamoxifen-induced fatty liver in patients with breast cancer. Lancet 1998; 351:725 (Pubitemid 28105346)
5. Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006; 239:105-112
6. Cho CS. Preoperative radiographic assessment of hepatic steatosis with histologic correlation. J Am Coll Surg 2008; 206:480-488 (Pubitemid 351282515)
7. Pilleul F, Chave G, Dumortier J, Scoazec JY, Valette PJ. Fatty infiltration of the liver: detection and grading using dual T1 gradient echo sequences on clinical MR system. Gastroenterol Clin Biol 2005; 29:1143-1147 (Pubitemid 43046359)
8. Robinson PJ. The effects of cancer chemotherapy on liver imaging. Eur Radiol 2009; 19:1752-1762
9. Ramachandran R, Kakar S. Histological patterns in drug-induced liver disease. J Clin Pathol 2009; 62:481-492
10. Kang SP, Taddei T, McLennan B, Lacy J. Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management. World J Gastroenterol 2008; 14:1622-1624 (Pubitemid 351460183)
11. Sandrasegaran K, Alazmi WM, Tann M, Fogel EL, McHenry L, Lehman GA. Chemotherapy-induced sclerosing cholangitis. Clin Radiol 2006; 61:670-678 (Pubitemid 44028493)
12. Martin RC, Edwards MJ, McMasters KM. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. Am J Surg 2004; 188:714-721
13. Robinson S, Manas DM, Pedley I, Mann D, White SA. Systemic chemotherapy and its implications for resection of colorectal liver metastasis. Surg Oncol [Epub 2009 Dec2]
14. Ho VT, Revta C, Richardson PG. Hepatic venoocclusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone Marrow Transplant 2008; 41:229-237 (Pubitemid 351260376)
15. Baumgaertner I, Ratziu V, Vaillant JC, Hannoun L, Poynard T, André T. Hepatotoxicity of metastatic colorectal cancer chemotherapy: systematic review. Bull Cancer 2010; 97:559-569
16. Rodriguez-Frias EA, Lee WM. Cancer chemotherapy. II. Atypical hepatic injuries. Clin Liver Dis 2007; 11:663-676 (Pubitemid 47302348)
17. Carreras E. Veno-occlusive disease of the liver after hemopoietic cell transplantation. Eur J Haematol 2000; 64:281-291 (Pubitemid 30307700)
18. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M. Severe hepatic sinusoidal obstruction associated with oxaliplatin based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004; 15:460-466 (Pubitemid 38444550)
19. Aloia T, Sebagh M, Plasse M, Karam V, Lévi F, Giacchetti S. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006; 24:4983-4990 (Pubitemid 46631400)
20. Iannaccone R, Federle MP, Brancatelli G, et al. Peliosis hepatis: spectrum of imaging findings. AJR 2006; 187:208; [web]W43-W52
21. Lindberg MC. Hepatobiliary complications of oral contraceptives. J Gen Intern Med 1992; 7:199-209
22. Anderson SW, Kruskal JB, Kane RA. Benign hepatic tumors and iatrogenic pseudotumors. RadioGraphics 2009; 29:211-229
23. Runzi M, Layer P. Drug-associated pancreatitis; facts and fiction. Pancreas 1996; 13:100-109
24. Farres MT, Ronco P, Saadoun D, et al. Chronic lithium nephropathy: MR imaging for diagnosis. Radiology 2003; 229:570-574 (Pubitemid 37310848)
25. Jones DP, Mahmoud H, Chesney RW. Tumor lysis syndrome: pathogenesis and management. Pediatr Nephrol 1995; 9:206-212
26. Del Toro G, Morris E, Cairo MS. Tumor lysis syndrome: pathophysiology, definition, and alternative treatment approaches. Clin Adv Hematol Oncol 2005; 3:54-61 (Pubitemid 40277560)
27. Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 2008; 26:2767-2778
28. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet 2006; 367:241-251 (Pubitemid 43107670)
29. Wall SD, Jones B. Gastrointestinal tract in the immunocompromised host: opportunistic infections and other complications. Radiology 1992; 185:327-335
30. Gorschlüter M, Strehl J, Ziske C, et al. Neutropenic enterocolitis in adults: systematic analysis of evidence quality. Eur J Hematol 2005; 75:1-13 (Pubitemid 40873955)
31. Sloas MM, Flynn PM, Kaste SC, Patrick CC. Typhlitis in children with cancer: a 30-year experience. Clin Infect Dis 1993; 17:484-490 (Pubitemid 23261468)
32. Kirkpatrick ID, Greenberg HM. Gastrointestinal complications in the neutropenic patient: characterization and differentiation with abdominal CT. Radiology 2003; 226:668-674 (Pubitemid 36259140)
33. Wade DS, Nava HR, Douglass HO Jr. Neutropenic enterocolitis: clinical diagnosis and treatment. Cancer 1992; 69:17-23
34. Shamberger RC, Weinstein HJ, Delorey MJ, et al. The medical and surgical management of typhilitis in children with acute non-lymphocytic (myelogenous) leukemia. Cancer 1986; 57:603-609 (Pubitemid 16164619)
35. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12:409-415
36. Pear BL. Pneumatosis intestinalis: a review. Radiology 1998; 207:13-19
37. Balthazar EJ, Yen BC, Gordon RB. Ischemic colitis: CT evaluation of 54 cases. Radiology 1999; 211:381-388 (Pubitemid 29206804)
38. Stolte M, Bethke B, Ruhl G, Ritter M. Omeprazole-induced pseudo-hypertrophy of gastric parietal cells. Z Gastroenterol 1992; 30:134-138
39. Driman DK, Wright C, Tongas G, et al. Omeprazole produces parietal cell hypertrophy and hyperplasia in humans. Dig Dis Sci 1996; 41:2039-2047 (Pubitemid 26366806)
40. Choudhry U, Boyce HW Jr, Coppola D. Proton pump inhibitor-associated gastric polyps. Am J Clin Pathol 1998; 110:615-621
41. Laine L, Ahnen D, Mcclain C, Solcia E, Walsh JH. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 2000; 14:651-668 (Pubitemid 30352732)
42. Scarsbrook AF, Warakaulle DR, Dattani M, Traill Z. Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances. Clin Radiol 2005; 60:47-55 (Pubitemid 40103899)
43. Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 2001; 3:70-78 (Pubitemid 32452921)
44. Shroff R, Rees L. The post-transplant lymphoproliferative disorder: a literature review. Pediatr Nephrol 2004; 19:369-377 (Pubitemid 38477398)
45. Borhani AA, Hosseinzadeh K, Almusa O, Furlan A, Nalesnik M. Imaging of post transplantation lymphoproliferative disorder after solid organ transplantation. RadioGraphics 2009; 29:981-1000
46. Neves-E-Castro M. Association of ovarian and uterine cancers with postmenopausal hormonal treatments. Clin Obstet Gynecol 2008; 51:607-617
47. Cohen I. Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol 2004; 94:256-266 (Pubitemid 39024525)
48. Loret de Mola JR. Endometrial changes with chronic tamoxifen use. Curr Opin Obstet Gynecol 1997; 9:160-164
49. Silva EG, Carmen ST, Follen-Mitchell M. Malignant neoplasms of the corpus in patients treated for breast carcinoma: the effect of tamoxifen. Int J Gynecol Pathol 1994; 13:248-258 (Pubitemid 24190983)
50. Ascher SM, Johnson JC, Barnes WA, Bae CJ, Patt RH, Zeman RK. MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation. Radiology 1996; 200:105-110 (Pubitemid 26197346)
51. Zaino RJ. Glandular lesions of the uterine cervix. Mod Pathol 2000; 13:261-274 (Pubitemid 30207511)
52. Bennett GL, Slywotzky CM, Giovannielo G. Gynecologic causes of acute pelvic pain: spectrum of CT findings. RadioGraphics 2002; 22:785-801
53. Lamm DL, van der Meijden PM, Morales A, et al. Incidence and treatment of complications of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol 1992; 147:596-600
54. Harding GE, Lawlor DK. Ruptured mycotic aortic aneurysm secondary to mycobacterium bovis after intravesical treatment with bacillus Calmette-Guérin. J Vasc Surg 2007; 46:131-134 (Pubitemid 46990735)
55. Landefeld CS, Beyth RJ. Anticoagulant related bleeding: clinical epidemiology, prediction and prevention. Am J Med 1993; 95:315-328 (Pubitemid 23270290)